SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001599901-24-000032
Filing Date
2024-02-29
Accepted
2024-02-29 16:06:10
Documents
18
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rna-20240228.htm   iXBRL 8-K 42762
2 EX-4.1 exhibit411490077562.htm EX-4.1 115870
3 EX-10.1 exhibit1011490073762.htm EX-10.1 319526
4 EX-99.1 exhibit9911490086192.htm EX-99.1 13935
8 image_0.jpg GRAPHIC 34724
  Complete submission text file 0001599901-24-000032.txt   768585

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rna-20240228.xsd EX-101.SCH 1931
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rna-20240228_lab.xml EX-101.LAB 24851
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rna-20240228_pre.xml EX-101.PRE 13067
20 EXTRACTED XBRL INSTANCE DOCUMENT rna-20240228_htm.xml XML 2829
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Filer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39321 | Film No.: 24703576
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)